Why beta blockers should be used in heart failure

Central African Journal of Medicine

Volumn 45, Issue 7, 1999, Pages 187-189

  Bhagat, K ^a   Hakim, J G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOTONIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

CONGESTIVE HEART FAILURE; DRUG COMBINATION; DRUG EFFECT; HEMODYNAMICS; HUMAN; MORTALITY; PATHOPHYSIOLOGY; REVIEW; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOTONIC AGENTS; DIURETICS; DRUG THERAPY, COMBINATION; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; TREATMENT OUTCOME;

EID: 0033155098     PISSN: 00089176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Waagstein F, Hjalmarson A, Varnauskas E. Effect of chronic beta-adrenergic blockade in congestive cardiomyopathy. Br Heart J 1975;37:1022-36.
2. Currie PJ, Kelly MJ, McKenzie A. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy. J Am Coll Cardiol 1984;3:203-9.
3. Ikram H, Fitzpatrick D. Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy. Lancet 1981;2:490-92.
4. Swedberg K, Waagstein F, Hjalmarson A. Beneficial effects of long-term beta blockade in congestive cardiomyopathy. Br Heart J 1980; 44:117-33.
5. Waagstein F, Bristow N4R, Swedberg K. Beneficial effect of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993;342:1441-6.
6. Rahman MA, Hara K, Senn BM Reductions in muscle sympathetic nerve activity after chronic beta-blockade for dilated cardiomyopathy [abstract]. Circulation 1993;88(suppl):1-415.
7. Eichorn EJ, Heesch CM, Barnett JH. Effect of metoprolol on myocardial function and energetics in patients with nonischaemic dilated cardiomyopathy. J Am Coll Cardiol 1994;24:1310-20.
8. The Cardiac Insufficiency Bisoprolol Study (CIBIS). A randomized trial of beta-blockade in heart failure. Circulation 1994;90:1765-73.
9. Swedberg K, Waagstein F, Hjalmarson A, Myers AD, Jonhsonn P. Prolongation of survival in congestive cardiomyopathy by beta receptor blockade. Lancet 1979;1:1374-76.
10. Packer M, Bristow MR, Cohn JN. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure: US Carvedilol Heart Failure Study Group. N Engl J Med 1996;334:1349-55.
11. Bristow MR, Gilbert EM, Abraham WT. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 1996;94:2807-16.
12. Colucci WS, Packer M, Bristow MR. Carvedilol inhibits clinical progression in patients with mild heart failure. Circulation 1996;94:2800-06.
13. Aldennan J, Grassman W. Are beta-adrenergic-blocking drugs useful in the treatment of dilated cardiomyopathy? Circulation 1985;71:854-7.
14. Packer DL, Bardy DA, Gallagher JJ. Tachycardia-induced cardiomyopathy. J Am Coll Cardiol 1984;3:521-6.
15. Bennett SK, Fisher ML, Krichten CM, Coloccui G, Thompson AD. Benefit of beta blockers in patients with ischemic cardiomyopathy does not correlate with change in heart rate [abstract]. Circulation 1994;90(suppl): 1-544.
16. Francis G. Comparison of neuroendocrine activity in patients with left ventricular dysfunction with or without congestive heart failure (SOLVD). Circulation 1990;82:1724-29.
17. Opie LH. Angiotensin converting inhibitors. 2nd ed. New York: Wiley-Liss, 1996:2-9.
18. Matsui S, FuL-X, Fukuoka T, Matsui H. Autoantibodies against G-protein coupled receptors in patients with dilated cardiomyopathv [abstract]. Circulation 1994;90(suppl):1-67.
19. Beta-blocker heart attack research. A randomized trial of propanolol in patients with acute myocardial infarction: 1. Mortality results. JAMA 1982;(1)247:1707-14.
20. White M, Michael E, Johns DD, Gilbert JA. Do beta-blocking agents improve left ventricular function in subjects with ischaemic dilated cardiomyopathy? [abstract]. J Am Col Cardiol 1993;21:115A.
21. Schwartz BM, Sackner-Bernstein J, Penn J. Which patients with chronic heart failure are most likely to show hemodynamic and functional improvement following long term beta-blockade? [abstract]. J Am Coll Cardiol 1992;19:34.
22. Cohn JN, Johnson G, Ziesche S. A comparison of enalapril with hydralizine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10.
23. Wilson AC, Zhong-Hua L, Kostis JB. Effect of beta blockers in patients with low ejection fraction. Circulation 1995;92(suppl L):1L-33L.